The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_001754.5(RUNX1):c.1197C>G (p.Ser399Arg)

CA410147801

2150091 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 9eee86f8-307c-4e57-8b85-47655fdec3b3
Approved on: 2024-07-17
Published on: 2024-07-17

HGVS expressions

NM_001754.5:c.1197C>G
NM_001754.5(RUNX1):c.1197C>G (p.Ser399Arg)
NC_000021.9:g.34792381G>C
CM000683.2:g.34792381G>C
NC_000021.8:g.36164678G>C
CM000683.1:g.36164678G>C
NC_000021.7:g.35086548G>C
NG_011402.2:g.1197331C>G
ENST00000675419.1:c.1197C>G
ENST00000300305.7:c.1197C>G
ENST00000344691.8:c.1116C>G
ENST00000399240.5:c.924C>G
ENST00000437180.5:c.1197C>G
ENST00000482318.5:c.*787C>G
NM_001001890.2:c.1116C>G
NM_001754.4:c.1197C>G
NM_001001890.3:c.1116C>G
More

Uncertain Significance

Met criteria codes 2
BP4 PM2_Supporting
Not Met criteria codes 24
PS1 PS2 PS4 PS3 PP1 PP4 PP3 PP2 PM6 PM5 PM1 PM3 PM4 PVS1 BS2 BS4 BS3 BS1 BP7 BP5 BP2 BP3 BP1 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.1197C>G (p.Ser399Arg) is a missense mutation that is not present in gnomAD v2.1.1 and v3.1.2 (PM2_supporting). This variant has a REVEL score < 0.50 (0.126), and a SpliceAI score ≤ 0.20 (0.0) (BP4). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria have been applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_supporting, BP4.
Met criteria codes
BP4
REVEL score = 0.126 which is below threshold for pathogenicity and SpliceAI score = 0.
PM2_Supporting
Variant is not present in gnomAD.
Not Met criteria codes
PS1
Not found.
PS2
Variant has not been reported in the literature.
PS4
Variant has not been reported in the literature.
PS3
Variant has not been reported in the literature.
PP1
Variant has not been reported in the literature.
PP4
This rule is not applicable for MM-VCEP
PP3
REVEL score = 0.126 which is below threshold for pathogenicity and SpliceAI score = 0.
PP2
This rule is not applicable for MM-VCEP
PM6
Variant has not been reported in the literature.
PM5
Other missense changes at this codon are also VUS.
PM1
This residue is not within the RUNX1 hotspot region.
PM3
This rule is not applicable for MM-VCEP
PM4
Variant is a missense mutation.
PVS1
Variant is a missense mutation.
BS2
This rule is not applicable for MM-VCEP
BS4
Variant has not been reported in the literature.
BS3
Variant has not been reported in the literature.
BS1
Variant is not present in gnomAD.
BP7
Variant is a missense mutation.
BP5
This rule is not applicable for MM-VCEP
BP2
Variant has not been reported in the literature.
BP3
This rule is not applicable for MM-VCEP
BP1
This rule is not applicable for MM-VCEP
BA1
Variant is not present in gnomAD.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.